Literature DB >> 31523295

Nutritional Status as a Risk Factor in COPD.

Anca Hancu1.   

Abstract

The third leading cause of death, chronic obstructive pulmonary disease COPD is gaining more and more attention in the literature and clinical practice. Precision medicine, already recognised as a right approach for COPD, requests a special attention to be allocated for nutritional status. Free fat mass index FFMI and visceral fat VFA area measurements should be added to body mass index (BMI) in order to have a complete perspective of the nutritional status and disease prognosis. Prospective medical nutrition therapy should consider caloric intake for achieving a BMI of 20-24 kg/m2, nutritionally dense, small and frequent meals, choosing the moment for the most important meal when the level of energy is the highest for the patient. A resting period before mealtime is adviced. Obesity paradox in COPD means a lower mortality associated with BMI between 25 and 32. This benefit is mainly related to higher muscular mass, as it has been described by some authors. The main objective in nutritional intervention will be to maintain muscular mass, adviced protein intake should be 1.2 g/kg body weight/day, higher vs general population. In the future, nutritional status evaluation should be included in pulmonary rehabilitation process, and a multidisciplinary team is expected to cooperate in order to achieve best pulmonary results.

Entities:  

Year:  2019        PMID: 31523295      PMCID: PMC6709393          DOI: 10.26574/maedica.2019.14.2.140

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  6 in total

1.  Association between adiposity measures and COPD risk in Chinese adults.

Authors:  Jiachen Li; Lu Zhu; Yuxia Wei; Jun Lv; Yu Guo; Zheng Bian; Huaidong Du; Ling Yang; Yiping Chen; Yonglin Zhou; Ruqin Gao; Junshi Chen; Zhengming Chen; Weihua Cao; Canqing Yu; Liming Li
Journal:  Eur Respir J       Date:  2020-04-30       Impact factor: 33.795

2.  Oral treatment for diabetes using α-glucosidase inhibitors was a risk factor for chronic obstructive pulmonary disease: a cohort study.

Authors:  Sheng-Wen Wu; Yung-Chyuan Ho; Ci-Wen Luo; Hung-Yi Chen; Chun-Hung Su; Yu-Hsiang Kuan
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

3.  Malnutrition, Sarcopenia, and Malnutrition-Sarcopenia Syndrome in Older Adults with COPD.

Authors:  Aleksandra Kaluźniak-Szymanowska; Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Marta Lewandowicz; Beata Kaczmarek; Katarzyna Wieczorowska-Tobis
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

4.  Health-Related Quality of Life and Nutritional Status Are Related to Dietary Magnesium Intake in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.

Authors:  Afsane Ahmadi; Mohammad Hassan Eftekhari; Zohreh Mazloom; Masoom Masoompour; Mohammad Fararooei; Morteza Zare; Najmeh Hejazi
Journal:  Clin Nutr Res       Date:  2022-01-31

Review 5.  Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.

Authors:  Hamad Ghaleb Dailah
Journal:  Molecules       Date:  2022-08-28       Impact factor: 4.927

6.  Exploration of n-6 and n-3 Polyunsaturated Fatty Acids Metabolites Associated with Nutritional Levels in Patients with Severe Stable Chronic Obstructive Pulmonary Disease.

Authors:  Mingshan Xue; Chuanxu Cai; Lili Guan; Yifan Xu; Jinsheng Lin; Yifeng Zeng; Haisheng Hu; Rongchang Chen; Hongman Wang; Luqian Zhou; Baoqing Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.